Current Status and Analysis of Drug Treatment for Acute Heart Failure Patients in Changchun City
Objective To understand the drug treatment status of patients with acute heart failure in Changchun,and provide reference for clinicians.Methods A total of 1 021 patients with acute heart failure in Changchun multiple hospitals were selected from March 2017 to March 2023,their personal information,drug usage and treatment results were collected,and the current situation of medication in Changchun was analyzed.Results Diuretics,intravenous vasodilators,and angiotensin converting enzyme inhibitor(ACEI)/angiotensin receptor blocker(ARB)were the main drugs for patients with acute heart failure in Changchun.The utilization rate of venous vasodilators was the highest,reaching 92.95%,and the utilization rate of diuretics was also relatively high,reaching 89.91%;followed by ACEI/ARB at 75.91%,and some patients using inotropic drugs and β blockers at 37.90%and 11.95%respectively.In addition,patients also have a variety of adverse drug reactions,such as hypotension,electrolyte disturbance,arrhythmia,gastrointestinal reactions.After treatment,some patients had readmission due to cardiac insufficiency,malignant arrhythmia and cardiac death.Conclusion Strengthen the standardized training of doctors on drug treatment for patients with acute heart failure,and improve doctors'understanding and ability to deal with adverse drug reactions,meanwhile,strengthen patient education to improve their self-management ability and reduce the occurrence of adverse drug reactions.
acute heart failuredrug treatmentadverse reactioncurrent treatment statuscurrent situation analysischangchun city
万方数据
维普
